Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
PF-07284892 in Participants With Advanced Solid Tumors - Drug Trials For Money - Paid Clinical Trials

PF-07284892 in Participants With Advanced Solid Tumors

PF-07284892 in Participants With Advanced Solid Tumors
Condition:   Solid Tumor
Interventions:   Drug: PF-07284892;   Drug: lorlatinib;   Drug: binimetinib;   Biological: cetuximab;   Drug: encorafenib
Sponsor:   Pfizer
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 25, 2021 / by / in
Comments